Showing results (11-20 of 155) with videos related to
Sort By:
Pageof 16
Current Pharmaceutical Biotechnology|May 11, 2011
Pharmacokinetic concepts revisited--basic and appliedKashyap Patel, Carl M J KirkpatrickAge and Ageing|March 22, 2021
New Horizons in the impact of frailty on pharmacokinetics: latest developmentsSarah N Hilmer, Carl M J KirkpatrickBritish Journal of Clinical Pharmacology|November 13, 2007
Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic studyStefanie Hennig, Ross Norris, Carl M J KirkpatrickThe Clinical Biochemist. Reviews|May 26, 2011
Drug dosing in renal diseaseMatthew P Doogue, Thomas M PolasekAustralian Prescriber|June 26, 2025
Using pharmacogenomics to personalise drug therapy: which drugs, when and howSophie L Stocker, Thomas M PolasekTherapeutic Advances in Drug Safety|March 30, 2018
Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patientsHeather L Forbes, Thomas M PolasekExpert Opinion on Drug Metabolism & Toxicology|June 2, 2007
In vitro approaches to investigate mechanism-based inactivation of CYP enzymesThomas M Polasek, John O MinersFrontiers in Medicine|June 20, 2025
Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trialThomas M Polasek, Peter L FriedlandClinical Pharmacology and Therapeutics|February 8, 2024
Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug ResponsesThomas M Polasek, Richard W PeckEuropean Journal of Clinical Pharmacology|January 18, 2006
Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrateThomas M Polasek, John O MinersPageof 16